<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its major risk factor, <z:hpo ids='HP_0001513'>obesity</z:hpo>, are a growing burden for public health </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanisms that connect <z:hpo ids='HP_0001513'>obesity</z:hpo> and its related disorders, such as <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo>, are still undefined </plain></SENT>
<SENT sid="2" pm="."><plain>Microvascular dysfunction may be a pathophysiologic link between <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> in <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Many studies have shown that adipose tissue-derived substances (adipokines) interact with (micro)vascular function and influence insulin sensitivity </plain></SENT>
<SENT sid="4" pm="."><plain>In the past, research focused on adipokines from perivascular adipose tissue (PVAT) </plain></SENT>
<SENT sid="5" pm="."><plain>In this review, we focus on the interactions between adipokines, predominantly from PVAT, and microvascular function in relation to the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>